Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Weifeng Liu1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China;3 Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Jie Hu1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Kaiqian Zhou1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Feiyu Chen1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Zheng Wang1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Boyi Liao1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Zhi Dai1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China

Ya Cao4 Cancer Research Institute, Central South University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Changsha, China

Jia Fan1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China;5 Institute of Biomedical Sciences, Fudan University, Shanghai, China

Jian Zhou1 Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China;2 Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China;5 Institute of Biomedical Sciences, Fudan University, Shanghai, China;6 Shanghai Key Laboratory of Organ Transplantation, Shanghai, ChinaCorrespondence[email protected]

show all

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Articles from other publishers (98)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Citations (105)

Read on this site (7)

Articles from other publishers (98)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date